Rexahn pharmaceuticals, inc. (REXN)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Revenues:

-

-

-

0

0

0

0

0

-

0

0

Expenses:
General and administrative

5,738

7,428

6,639

6,324

6,115

6,253

4,725

2,713

3,547

5,990

2,944

Research and development

5,476

13,109

10,715

10,089

12,148

7,015

3,253

3,392

11,992

3,934

3,176

Patent fees

-

-

-

-

-

-

-

431

546

329

303

Depreciation and amortization

-

-

-

-

-

-

-

42

45

50

41

Total Expenses

11,215

20,537

17,354

16,413

18,263

13,269

7,978

6,579

16,131

10,305

6,465

Loss from Operations

-11,215

-20,537

-17,354

-16,413

-18,263

-13,269

-7,978

-6,579

-16,131

-10,305

-6,465

Other Income
Realized loss on marketable securities

-

-

-

-

-

-

-

-

-3

0

11

Interest income

313

254

207

118

103

133

49

21

109

133

67

Interest expense

-

-

-

-

-

-

-

-

-

0

0

Other income

-

368

-

-

-

-

-

-

-

56

0

Unrealized (loss) gain on fair value of warrants

-2,265

-5,546

7,594

-

-

-

-

-

-

-

-

Mediation settlement

-

-

-

1,770

-

-

-

-

-

-

-

Unrealized (loss) gain on fair value of warrants

-

-

-

5,529

3,986

-5,180

-

-

-

-

-

Unrealized gain on fair value of warrants

-

-

-

-

-

-

1,365

-663

-4,778

3,823

-1,793

Unrealized gain on fair value of put feature on common stock

-

-

-

-

-

-

-

-

-

-97

-1,915

Financing expense

-

-

552

313

211

206

204

332

97

180

223

Beneficial conversion feature

-

-

-

-

-

-

-

-

-

0

0

Total Other (Loss) Income

2,579

6,169

-7,939

7,106

3,878

-5,252

-1,520

352

4,786

-3,716

3,562

Net Loss Before Provision for Income Taxes

-8,635

-14,368

-25,294

-9,307

-14,384

-18,521

-9,499

-6,226

-11,344

-14,022

-2,903

Provision for Income Taxes

-

-

-

0

0

0

0

0

-

0

0

Net Loss

-8,635

-14,368

-25,294

-9,307

-14,384

-18,521

-9,499

-6,226

-11,344

-14,022

-2,903

Net loss per share, basic and diluted

-2.18

-5.25

-0.92

-0.43

-0.79

-0.11

-0.07

-0.06

-0.12

-0.18

-0.05

Weighted average number of shares outstanding, basic and diluted

3,960

2,738

27,390

21,744

18,238

176,106

128,649

97,138

93,048

-

-

Weighted Average number of shares outstanding, basic and diluted

-

-

-

-

-

-

-

-

-

78,662

61,441